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Abstract 
Objective: The study aimed to 1) investigate the effect of treatment location on clinical 
outcomes for patients receiving psychological therapy (a clinic effect, akin to the concept of a 
therapist effect), and 2) assess the impact of explanatory individual and aggregate 
demographic and process variables on the clinic and therapist effects. 
Method: The sample comprised 26,888 patients, seen by 462 therapists, across 30 clinics. 
Mean patient age was 38 years (69% female, 90% White, 92% planned ending). The 
dependent variable was SDWLHQWV¶post-therapy score on the Clinical Outcomes in Routine 
Evaluation ± Outcome Measure.  An incremental three-level multilevel model was 
constructed. Markov Chain Monte Carlo estimation created 95% probability intervals for the 
clinic and therapist effects. 
Results: A three-level model with no explanatory variables detected a clinic effect of 8.2%, 
significantly larger than the therapist effect of 3.2%. Adding explanatory variables 
significantly reduced the clinic effect to 1.9% but did not significantly alter the therapist 
effect (3.4%). Patient-level symptom severity and employment status, and clinic-level 
percentage of White patients and healthcare sector explained the most clinic outcome 
variance and overall outcome variance.  
Conclusions: Substantial variability in clinical outcomes was found between clinics providing 
psychological therapy. Socioeconomic mix of patients explained significant proportions of 
variability at the clinic level but not the therapist level. Clinical implications include the need 
to go beyond the therapist-patient interaction in order to deliver effective psychological 
therapy. Future research is also needed to identify the mechanisms by which clinic and/or 
area-level factors impact on clinical outcomes. 
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Public Health Significance Statements: This study demonstrates that typical outcomes for 
people receiving psychological therapy vary systematically across clinics in the UK. Levels 
of (un)employment and ethnic/racial composition may help to explain between-clinic 
differences in effectiveness. It is important to consider the broader socioeconomic and 
geographic context in which therapy is offered to improve the effectiveness of psychological 
interventions.  
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Substantial variability exists in the extent of symptom improvement and other benefits 
from psychological therapies (Baldwin & Imel, 2013; Barkham, Lutz, Lambert, & Saxon, 
2017; Bohart & Greaves Wade, 2013). Such findings occur regardless of whether researchers 
adopt a trial design (e.g., Vittengl et al., 2016) or employ practice-based datasets (e.g., Pybis, 
Saxon, Hill, & Barkham, 2017).  Much of this variability in outcomes is understood to 
depend on patient factors - particularly initial symptom severity and socio-economic 
deprivation, with more severe or deprived patients having poorer outcomes (Bohart & 
Greaves Wade, 2013; Hamilton & Dobson, 2002). Evidence also suggests that process factors 
such as the number of sessions attended by patients, as well as patient engagement, are 
related to clinical outcome (Barrett, Chua, Crits-Christoph, Gibbons, & Thompson, 2008; 
Bohart & Greaves Wade, 2013; Stulz, Lutz, Kopta, Minami, & Saunders, 2013).  
Therapists also contribute to this variability, however. Some therapists consistently 
deliver better outcomes than other therapists, even after controlling for patient factors in their 
case mix (e.g., Baldwin & Imel, 2013; Barkham, Lutz, Lambert, & Saxon, 2017; Saxon & 
Barkham, 2012). This therapist effect typically accounts for between 5-10 per cent of 
variance in patient outcomes (Baldwin & Imel, 2013; Johns, Barkham, Kellett, & Saxon, 
2018). Therapist characteristics associated with this effect include empathy, alliance, 
professional self-doubt, and deliberate practice (Goldberg et al., 2016; Nissen-Lie et al., 
2015; Wampold, Baldwin, grosse Holtforth, & Imel, 2017). 
Similarly, the clinic where a patient is seen may also have an effect. Studies of multiple 
healthcare organizations and clinics show considerable variability in outcomes (Delgadillo, 
Asaria, Ali, & Gilbody, 2016; Royal College of Psychiatrists, 2013). Controlling for patient 
factors, a clinic (or site) effect of 1.8 per cent was found by Pybis et al. (2017), indicating the 
amount of variance in patient outcomes attributable to differences between clinics.  Clinic 
effects may reflect systematic differences in clinical population characteristics, therapist 
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recruitment practices, resource allocation, accessibility, etc. Additionally, clinic effects may 
reflect geographic and socio-economic factors in their patient population, such as levels of 
social support, safety, adequate housing, and socioeconomic deprivation (Barkham, 
Delgadillo, Firth, & Saxon, 2018; Clark et al., 2018; Delgadillo et al., 2016). This latter kind 
of effect may be more aptly termed a neighborhood effect. Although there is little research 
into neighborhood effects on psychological therapy outcomes, there is growing evidence that 
the local neighborhood impacts individual physical health (e.g. Pickett & Pearl, 2001).  
In summary, patient, therapist, and clinic factors can all contribute to the variability in 
patient outcomes. However, little is known about how these three sources relate and interact 
with each other to produce the variability reported in the literature. Just as therapist effects 
research has produced therapist-targeted interventions, research into clinic effects could lead 
to clinic level interventions to address contributing factors and improve outcomes.  
Although studies of therapist and clinic effects have controlled for patient variables, 
therapist effect estimates have been derived from either a single clinic (e.g., Firth, Barkham, 
Kellett, & Saxon, 2014) or did not consider differences between clinics in the analysis (e.g., 
Green, Barkham, Kellett, & Saxon, 2014). Similarly, clinic effect estimates have not 
considered differences between therapists (Pybis et al., 2017).  Despite these shortcomings 
due largely to sample limitations, such studies have identified important interactions between 
therapists and patient variables, and between clinics and patient variables. Most consistently, 
the effect of initial severity on patient outcomes has been found to vary between therapists 
and between clinics (Pybis et al., 2017; Schiefele et al., 2016). Also, therapists vary in how 
the number of sessions attended affects outcomes (Saxon, Firth, & Barkham, 2017). 
The three sources of variability (patient, therapist and clinic) are not independent ± they 
are levels with a hierarchical structure. Patients are nested within therapists, who are in turn 
nested within clinics. To assess relative influences in such cases, multilevel modeling (MLM) 
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methods are recommended (Goldstein, 2010; Snijders & Bosker, 2012). MLM explicitly 
models variability as statistical variance at each level simultaneously, whilst appropriately 
modeling explanatory variables at each level (for example, accounting for patient case mix) 
and any interactions between levels (Raudenbush & Bryk, 2002; Snijders & Bosker, 2012). 
Such methods require large samples of patients, therapists and clinics, which are more likely 
to come from naturalistic settings than from randomized controlled trials (Elkin, 1999).  
The aims of the current study were two-fold. First, to estimate the size of therapist and 
clinic effects in a heterogeneous, naturalistic sample of patients receiving psychological 
therapies. Second, to assess the impact on outcome of the relationships between patient 
demographic and process variables and the variability between therapists and between clinics. 
We hypothesized that a significant clinic effect would be detected despite controlling for 
therapist variability and patient variables. We expected that patient variables (particularly 
symptom severity) might partly explain clinic effects, whether at the patient level or in 
aggregate, but had no clear hypotheses regarding the extent to which this would occur. 
Method 
Study dataset 
The study sample was drawn from the CORE National Research Database 2011 (see 
Stiles, Barkham, & Wheeler, 2015). The initial database comprised 104,474 patients seen by 
2,442 therapists at 52 psychological therapy clinics across the United Kingdom (UK). Ethical 
approval was covered by National Research Ethics Service application 05/Q1206/128 
(amendment 3). The therapists were counselors, psychotherapists and clinical psychologists. 
Individual therapist characteristics data were unavailable in this database. The most common 
psychological intervention models delivered to patients included person-centered, 
psychodynamic, cognitive behavioral and supportive therapies. The mean unplanned ending 
rate per therapist was 33.0% (SD = 28.4), and per site was 33.5% (SD = 11.4). 
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Included clinics were from predominantly urban areas and ranged across five sectors of 
care provision: primary care, secondary care, university, voluntary, or workplace. All 
patients from two additional sectors (tertiary and private) were excluded in the process of 
applying the exclusion criteria below. Contributing factors included exceedingly high 
percentages of missing data in the tertiary sector (95% of patients had required data missing), 
and relatively low initial patient numbers in the private sector (n = 442).  
In the UK mental health services delivery system, primary, secondary, and tertiary care 
are typically offered in separate National Health Service (NHS) settings within a region. The 
primary care sector, which includes community health centers and general practitioner clinics 
(family practices) offering predominantly short-term counseling, is usually the first point of 
contact. Secondary and tertiary clinics are more specialized, provide longer-term 
psychotherapy, and usually require referrals from a primary care clinic. Patients can also 
access therapy through voluntary organizations and charities, in university and workplace 
counseling centers, or in private practices.  For patients, mental health services are typically 
free at the point of delivery except in the private sector. 
In selecting patients for analysis, patient inclusion criteria were applied first, followed 
by therapist and clinic inclusion criteria. These criteria aimed to produce a sample that would 
provide adequate sample sizes of patients, therapists and clinics to produce robust estimates 
of effects at each level (Schiefele et al., 2016). 
Patient inclusion criteria were as follows: 1) patient age was between 16 and 95 years 
old; 2) patients received an individual intervention (rather than a group, family, or couple 
intervention); 3) patient ethnic origin, employment status, and attendance data were recorded; 
and 4) valid pre- and post-treatment outcome measure scores were recorded. Therapist and 
clinic inclusion criteria were as follows: 1) each therapist worked with 10 or more eligible 
patients, and 2) each clinic included 5 or more eligible therapists. These criteria reduced the 
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original sample of 104,474 patients to 26,888 as shown in Figure 1. 
The final sample of 26,888 patients had a mean (SD) age of 38.4 (12.94) years and 
69.3% were female. They were seen by 462 therapists, across 30 clinics with a mean (SD) 
number of patients per therapist of 58.2 (71.4) and mean (SD) number of therapists per clinic 
of 15.4 (12.4). In this study sample, the mean recorded rate of unplanned endings per 
therapist was 9.0% (SD = 8.8), and per site was 9.2% (SD = 6.9).  
Measures 
Clinical Outcomes in Routine Evaluation Outcome Measure. (CORE-OM). The 
CORE-OM (Barkham et al., 2001; Evans et al., 2002) is a 34-item measure of psychological 
distress. Items assess the following domains: symptoms (depression, anxiety, physical 
problems, and trauma), functioning (general functioning, and in close and social 
relationships), subjective wellbeing, and risk (to self and others). Each item is scored on a 5-
point scale from 0-4. Items are anchored as follows: not at all, only occasionally, sometimes, 
often, and all or most of the time. Item scores are averaged and multiplied by 10 to produce a 
full measure clinical score of 0-40 with higher scores indicating greater distress. A clinical 
cut-off score of 10 has been found to optimally discriminate clinical and non-clinical samples 
(Connell et al., 2007). The CORE-OM demonstrates internal consistency of Į = .93-.95 
(Barkham, Gilbert, Connell, Marshall, & Twigg, 2005), test-retest reliability of .88 at one-
month intervals (Barkham, Mullin, Leach, Stiles, & Lucock, 2007), and strong convergent 
validity with measures such as the Beck Depression Inventory (BDI-II) and Clinical 
Interview Scale ± Revised (CIS-R) (Cahill et al., 2006; Connell et al., 2007). In this study the 
CORE-OM was administered prior to the first therapy session and following the last therapy 
session as part of routine practice at all clinics. As it was not collected every therapy session, 
patients who dropped out of treatment rarely had a measure for their last session attended. 
Although the CORE-OM score at the last session was the study outcome, comparisons 
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of effectiveness also considered statistically reliable, clinically significant pre-post change 
using the methods described by Jacobson and Truax (1991). A pre-post change of 5 points or 
more on the CORE-OM was taken as statistically reliable change, while change from above 
the clinical cut-off of 10 to below was clinically significant (Connell et al., 2007). Patients 
who met both of these criteria at outcome were considered statistically recovered. 
The CORE Assessment form and CORE End of Therapy form. These forms are 
completed by therapists at intake and the end of therapy respectively. They record referral 
information, patient demographics (gender, age, employment status, ethnic origin), data on 
the nature, severity and duration of presenting problems, the number of sessions the patient 
attended, whether the ending was planned or unplanned, and which type(s) of therapy the 
patient received (Mellor-Clark, Barkham, Connell, & Evans, 1999).  Ethnic origin, which 
became important in our analyses, was recorded in nine categories originally drawn from a 
UK government list 
(https://www.ons.gov.uk/methodology/classificationsandstandards/measuringequality/ethnicg
roupnationalidentityandreligion#ethnic-group): 1 Asian (Bangladeshi); 2 Asian (Indian); 3 
Asian (Pakistani); 4 Asian (E. African); 5 Asian (Chinese); 6 Black (African) ; 7 Black 
(Caribbean) ; 8 White (English/European) ; and 9 Other. 
Study sample characteristics 
No formal diagnoses were available in the dataset. However, most patients were 
reported by therapists to be experiencing anxiety (71.8%) and/or depression (54.0%), with 
14.6% and 7.3% respectively at a severe level. Incidence of depression was broadly similar 
across sectors, but the secondary care sector had the highest proportion at the severe level 
(12.0%). Secondary care was also characterized by a much larger proportion of patients with 
personality problems (37.2% with 7.9% at a severe level) compared to other sectors which 
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ranged from 1.6% to 3.5%, with between 0.2% and 0.4% at a severe level.  
Overall, the mean (SD) CORE-OM score pre-therapy was 17.8 (6.25); scores ranged 
from 17.2 (6.53) in the voluntary sector to 21.1 (7.05) in secondary care. Similarly, the 
proportion meeting criteria for clinical distress ranged from 85.9% in the voluntary sector to 
94.1% in the secondary care sector with an overall rate of 89.4%. 
Table 1 describes the study sample and shows comparisons between included and 
excluded patients. Effect sizes are also shown. Included patients were on average older, more 
likely to be female, White, and employed, had lower pre- and post-therapy outcome scores, 
attended more sessions and a higher proportion of offered sessions, and were more likely to 
have a planned ending (all p-values <0.001; all significant after Bonferroni correction). 
Patients of therapists excluded due to having fewer than 10 patients with eligible data (Figure 
1) had significantly less pre-post improvement in CORE-OM scores (M = 8.3, SD = 6.9, n = 
3,326) compared with patients of therapists with 10 or more eligible patients (M = 9.0, SD = 
6.7, n = 28,147), t(4100.0) = -5.7, p <. 001. Note that completion of treatment was not 
required for inclusion; however, completion of both pre- and post-treatment measures was 
required. Because relatively few patients who dropped out of treatment completed all 
measures, most (92%) of the included clients were treatment completers. 
Explanatory variables  
Patient level variables were: pre-treatment CORE-OM score, age, employment status, 
ethnic origin, sessions planned, sessions attended, and percentage of planned sessions 
attended. Two patient demographic variables, employment status and ethnic origin, were 
collapsed due to small numbers in some categories. Employment status was coded as: 
employed (comprising part-time employment, full-time employment), not employed 
(comprising receiving welfare benefits, unemployed, retired), or other role (comprising part-
time student, full-time student, houseperson, other). Also, as 87% of the population of the UK 
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is White (Office for National Statistics, 2011), with the remaining 13% representing a 
number of non-White race/ethnicity groups, non-White groups were collapsed into a single 
category. Using the UK ethnic origin categories on the CORE Assessment form (see list 
shown earlier; Evans et al., 2002), ethnic origin was recoded as White (i.e., category 8 White 
[English/European]), which accounted for 90.2% of the patients, versus Non-white (all other 
categories). 
Therapist-level and clinic-level aggregates of patient level variables were derived from 
the original database of all patients (N = 104,474). This produced therapist and clinic level 
explanatory variables to represenWWKHFRPSRVLWLRQRIHDFKWKHUDSLVW¶VFDVHORDGDQGHDFK
FOLQLF¶VFOLQLFDOSRSXODWLRQ7KHUHIRUHLQWRWDOWKHUHZHUHSRWHQWLDOH[SODQDWRU\YDULDEOHV 
as follows: Seven patient-level variables, an aggregate of each patient-level variable at the 
therapist and clinic level (14 total), and a variable specifying the sector of the clinic.   
Multilevel modeling analysis 
The primary analysis comprised multilevel modeling using the MLwiN software 
(Rasbash, Charlton, Browne, Healy, & Cameron, 2016). The post-therapy CORE-OM score 
was the dependent variable. This and the pre-therapy CORE-OM scores were log-
transformed to correct issues of heteroskedasticity. Models were developed from a single 
level model to two- and then three-level models with each development tested for 
significance by comparing the reduction in the -2*loglikelihood value against the chi-square 
critical value for the additional degrees of freedom. Significant reductions indicate 
improvements in model fit. Significance of random effects additionally required reductions in 
deviance information criterion (DIC) values dervied from Markov Chain Monte Carlo 
(MCMC) simulation.  
Due to the large number of explanatory variables, a Bonferroni correction was applied 
to z-score testing of model coefficients for all main effect, interaction, and random slope tests 
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in order to correct the family-wise error rate. The Bonferroni correction was calculated a 
priori on the basis of the number of explanatory variables (22). Thus, the resulting (more 
conservative) z-score critical value of 3.06 was used (corresponding to a per-observation p-
value of .0023, or 99.8% confidence). 
Patient-level, therapist-level, and clinic-level variables were tested for significance, 
followed by interactions between significant variables, and finally random slopes at both the 
therapist and clinic level. Each significant variable was then tested in isolation within a three-
level model and variables ranked according to the overall unexplained variance that each 
variable explained, and a final model was then reconstructed by adding variables in order 
from highest to lowest variance explained.  The therapist effect and clinic effect were 
recalculated after each variable was added. As is standard, these effects were defined as the 
percentages of overall unexplained (or residual) variance associated with the therapist level or 
clinic level respectively, and are akin to intra-class correlation coefficients (Rasbash, Steele, 
Browne, & Goldstein, 2012). Clinic and therapist effects represent the degree to which the 
variability between clinics and the variability between therapists in a clinic are associated 
with patient outcomes.  
Iterative Generalised Least Squares (IGLS) estimation was used in the construction of 
each model as variables were added and tested. Markov Chain Monte Carlo (MCMC) 
simulation procedures were then applied to a) the 1-level, 2-level, and 3-level model with no 
explanatory variables, b) the final 3-level model after inclusion of all significant variables, 
and c) two 2-level variants of the final model, in order to compare variance distributions and 
calculate DIC values. MCMC simulation used parameter estimates produced by IGLS as 
µSULRUV¶WRSURGXFHDFKDLQRISDUDPHWHUHVWLPDWHVIURPZKLFKPHGLDQVDQGPHDQVFRXOGEH
derived. In addition, MCMC allowed for the calculation of 95% probability intervals (PrIs) 
around estimates of effects. These are similar to confidence intervals and represent the 2.5 
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and 97.5 percentile values in the simulation chain (Browne, 2016).  
A sensitivity analysis was carried out using a modified sample, including only clinics 
with 10 or more therapists per clinic. This reduced the potential bias due to therapist outliers, 
but also reduced the number of clinics in the sample and confidence in clinic-level estimates.  
Results 
Initial analysis considered treatment effectiveness assessed by outcome scores and 
recovery rates. The results are presented overall, by therapists, and by clinics. These are 
followed by the development of the multilevel model, the identification of significant 
explanatory variables and the therapist and clinic effect estimations. Finally, the relationships 
between variables at the different levels in the model are considered in more detail. 
Outcomes 
For patients, the mean (SD) CORE-OM outcome score was 8.8 (6.33) with a mean (SD) 
pre- to post-therapy change of 9.0 (SD = 6.69). Of patients scoring above the clinical cut-off 
(i.e., CORE-OM score t10 or more) at pre-therapy (n = 24,027), 58.4% met the criteria for 
reliable and clinically significant improvement (RCSI).  
The mean (SD) RCSI rate for clinics was 57.5% (13.02) with a range across the 30 
clinics of 23.4% - 75.2%. The mean (SD) rate for therapists was 57.3% (17.00), with a range 
across the 462 therapists of 6.7% - 100%, although the number of patients from which these 
were derived was small in many cases. Considering only therapists who saw 50 or more 
patients (n = 129), the range was 15.5% to 91.1%. 
Multilevel model development 
A single, patient-level outcome model was compared with a 2-level model, with 
patients at level 1, a random intercept for therapists at level 2, and no explanatory variables. 
The 2-level model showed a significant improvement in model fit (Ȥ2(1) = 1801.51; p < 
0.001; reduction in DIC = 2283.34). A random intercept for clinics added at level 3 to 
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produce a simple 3-level model was a further significant improvement (Ȥ2(1) = 216.99; p < 
0.001; reduction in DIC = 76.92).  
Potential predictor variables, interactions, and random slopes were then tested for 
significance to produce a final model containing the statistically significant variables (full 
model specification available online as Supplemental Material). Following the inclusion of 
significant fixed effect variables, the multilevel model fit was re-tested. Recognizing the 
therapist level and clinic level again improved model fit, with significant reductions in 
-2*loglikelihood values (Ȥ2(1) = 870.66; p < 0.001 and Ȥ2(1) = 52.93; p < 0.001 respectively).  
Of seven random slopes tested, slopes for intake severity and attendance at the therapist 
level also improved model fit (Ȥ 2(2) = 24.64; p < 0.001; reduction in DIC = 32.47, and Ȥ2(3) 
= 25.17; p < 0.001; reduction in DIC = 37.24 respectively), indicating that the relations 
between intake severity and outcome, and attendance and outcome varied between therapists. 
The positive covariances with outcome for these two variables (0.004 and 0.003 respectively; 
see Supplementary Material) indicate that the variability between therapists increased as 
patient severity increased and attendance increased. However, for the latter, the standard error 
indicates uncertainty regarding the extent of the differences in the slopes. There were no 
significant random slopes for the clinic level. The final model, including significant 
explanatory variables, reduced the overall unexplained variance in the original 3-level empty 
model by 23.2%.  Model assumptions of homoscedasticity and Normality of residuals at each 
level were tested and met. MCMC simulation indicated 40,000 iterations were sufficient for 
the convergence of model estimates. 
Explanatory variables 
Of the seven patient level variables, intake severity, employment status, ethnic origin, 
age, and attendance were significant predictors of outcome (all p<.001), while sessions 
planned and sessions attended were not significant. Greater intake severity, not being 
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employed, being of non-White ethnic origin, being older and attending a lower percentage of 
planned sessions were associated with poorer outcome. Of the ten interactions between the 
five significant patient variables, only the interaction between severity and employment status 
was significant (p<.001). The effect of severity on outcome was greater for patients who were 
not employed, compared with patients who were employed. 
For sector, a clinic level variable, there were no significant differences between the 
coefficients for primary care, university, voluntary, and workplace clinics, therefore they 
were collapsed into one category and compared to secondary care clinics. The model results 
indicated that secondary clinics were associated with poorer outcomes (p<.001).  
No variables aggregated at the therapist level were significant in the model. However, 
patient ethnic origin aggregated at the clinic level, to represent the percentage of patients 
treated at the clinic who were White, was associated with outcome (p<.001).  A larger 
proportion of White patients in a clinic population was associated with improved clinic 
outcomes for both White and non-White patients compared to clinics with a lower proportion 
of White patients. This was in addition to the effect of individual patient ethnic origin. All ten 
cross-level interactions and the one clinic-level interaction tested were all non-significant. 
Clinic and therapist effects 
The final 3-level model produced a clinic effect of 1.9% (PrI = 0.8% ± 3.7%) and a 
therapist effect of 3.4% (PrI = 2.7% ± 4.2%) after controlling for fixed effect explanatory 
variables. In order to assess how the recognition of a third level affected these effects, two 2-
level models were constructed (patient/clinic and patient/therapist respectively).  In these 
models, a clinic effect of 2.8% (PrI = 1.5% ± 4.8%) and a therapist effect of 4.9% (PrI = 4.0% 
- 5.9%) were found, indicating that recognition of the third level reduced each effect by about 
30%.  
Figure 2 describes the variability between clinics and therapists in the final 3-level 
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model by plotting their model residuals with 95% confidence intervals (CIs). These represent 
the unexplained outcome variability associated with individual clinics and individual 
therapists. More effective clinics and therapists are shown on the left of the charts, indicating 
a larger reduction in the log-transformed outcome scores.  
In Figure 2, the dashed lines, where the residuals are zero, represent the average clinic 
or therapist, and only those clinics or therapists whose 95% CIs do not cross zero can be 
considered significantly different from average. Figure 2 indicates 4 (13.3%) clinics were 
more effective than average while 2 (6.7%) clinics were less effective than average and the 
difference between these two groups of clinics was significant as their 95% CIs did not 
overlap. The patient recovery rate for the more effective clinics was 69.7%, while the rate for 
patients seen at the less effective clinics was 48.5%. The recovery rate for patients seen at the 
majority of clinics, considered to be average, was 55.7%. Similarly, 18 (3.9%) therapists 
were more effective than average with an overall patient recovery rate of 77.2% compared 
with a rate of 41.4% for the 18 (3.9%) therapists who we less effective. The recovery rate for 
the 426 (92.2%) average therapists was 58.0%.  
A sensitivity analysis was conducted on a sub-sample that required 10 or more 
therapists per clinic, compared with 5 or more therapists per clinic in the main analysis. This 
sub-sample comprised 22,535 patients, seen by 394 therapists, across 19 clinics. Results were 
generally comparable. All significant explanatory variables in the main analysis remained 
significant in the sensitivity analysis and the final clinic effect (1.7%, PrI = 0.6% - 3.8%) and 
therapist effect (3.6%, PrI = 2.8% - 4.6%) also approximated those in the main analysis.  
Explaining the clinic effect 
During model development, the 3-level model with no explanatory variables indicated a 
clinic effect of 8.2% (PrI= 4.8% ± 13.6%), significantly larger than the therapist effect of 
3.2% (PrI = 2.5% - 4.0%). However, as noted above, in the final model, the clinic effect was 
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much reduced to 1.9%, indicating that the variables in the model explained 76.8% of the 
initial clinic effect. In contrast, the therapist effect in the final model had changed little, at 
3.4% (Figure 3).  
Figure 4 describes the changes in clinic and therapist effects as each variable, 
interaction, and random slope was added to the model. These were added in order of the 
percentage of the overall residual variance each explained when added in isolation to the 
empty 3-level model. The effects in Figure 4 were estimated using IGLS, which produced 
slightly smaller estimates than MCMC. Figure 4 also shows that patient severity, patient 
employment status, sector of the clinic, and the proportion of White patients in the clinic 
population explained most of the variability between clinics. Table 2 shows the percentages 
of residual variance from the empty 3-level model explained as each fixed effect variable was 
added. 
Table 2 shows that patient severity explained 29.6% of the initial clinic level variance, 
as well as the largest proportion of variance at the therapist level (12.4%) and patient level 
(16.2%). Other variables explained little additional variance at the therapist and patient 
levels, but patient employment status (16.4%), clinic sector (16.1%), and the proportion of 
White patients in the clinic population (19.6%) explained considerable amounts of clinic 
level variance. The remaining variables explained around 1% of clinic level variance.  
Ethnic origin and outcomes 
Figure 4 and Table 2 indicate that in addition to the proportion of White patients in 
the clinic population being a significant predictor of outcome, it also explained a large 
amount of the variance at the clinic level. To describe how this variable and the patient level 
ethnic origin variable predict patient outcomes, Figure 5 plots the predicted CORE-OM 
outcome scores (not log-transformed) for White and non-White patients treated at clinics with 
different percentages of White patients in their populations. The lines represent predicted 
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outcome scores for patients with mean or reference category values on other variables in the 
model. 
Figure 5 shows that White patients on average had better outcomes than non-White 
patients regardless of the ethnic composition of the clinic population, and that outcomes 
improve for both White and non-White patients at clinics with higher proportions of White 
patients.  In addition, Figure 5 also suggests that the difference between outcomes for White 
and non-White patients increased at clinics with higher proportions of White patients. 
However, this difference between around 0.25 of a point on CORE-OM for populations with 
the smallest proportions of White patients and around one point for the populations with the 
largest proportions of White patients (see Figure 5), was not significant in the final model. 
The removal from the model of either of the ethnic origin variables made little or no 
difference to the model coefficient of the other remaining ethnic origin variable. 
Discussion 
To our knowledge, this study is the first to use a 3-level multilevel model comprising 
clinics, therapists, and patients to model patient outcomes in psychological therapy. Our 
results indicate that modeling a hierarchical, nested structure in the data produced the best fit, 
and was able to identify predictors of outcome and estimate the size of clinic and therapist 
effects in a single model. The model was also able to describe the relationships and 
interactions between different factors across the three levels, and how these contributed in 
different ways to the variability in patient outcomes.  
Patient variables 
Supporting findings from previous MLM studies, the results show that most of the 
variability in patient outcomes was associated with differences between patients (e.g., Saxon 
& Barkham, 2012; Wampold & Brown, 2005). Also, the patient variables associated with 
outcome and explaining much of that variability (in particular intake severity, as well as 
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employment status, ethnic origin, age and sessions attended) have been identified previously 
(e.g., Firth et al., 2015; Garfield, 1994). However, in the current study, the relations between 
outcomes and these variables have been estimated while also controlling for the relations 
with both clinics and therapists.  
Cross-level interactions were also found. The significant effects of intake severity and 
attendance on outcome were found to be moderated by the therapist that the patient saw. In 
contrast, the effects of patient employment status, age and ethnic origin were the same 
regardless of the therapist. These findings are perhaps unsurprising as patient symptom 
severity is more directly linked to the therapeutic process and arguably by extension, the 
therapist. The relations between the patient variables and patient outcome were similar for all 
clinics; that is, there was no significant effect of random slopes. However, patient ethnic 
origin, aggregated to represent the ethnic composition of the clinic population, was found to 
explain a considerable amount of the variability between clinic outcomes. 
Therapist effects 
The therapist effect of 3.4% was smaller than the effects most commonly found of 
between 5% and 10% (Baldwin & Imel, 2013). However, the current study also included the 
clinic level in the model; excluding the clinic level produced a therapist effect of 4.9%, more 
similar to published effects (Johns et al., 2018). Thus, one potential reason for larger effects 
found elsewhere is that they may incorporate an unrecognized clinic effect.  
The size of the therapist effect may appear small, but it was both statistically 
significant and clinically significant. Patients were almost twice as likely to recover if seen by 
above average therapists compared with below average therapists. In addition, as noted 
above, the effect of random therapist slopes for patient intake severity and attendance indicate 
WKDWWKHUHZDVJUHDWHUYDULDELOLW\EHWZHHQWKHUDSLVWVWKHPRUHVHYHUHWKHSDWLHQW¶VFRQGLWLRn. 
This finding is consistent with other large studies of therapist effects (e.g., Berglar et al., 
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2016; Schiefele et al., 2016) and indicates that more effective therapists are particularly more 
effective in the treatment of more severe patients. 
Unlike the clinic effect, the therapist effect remained consistent after controlling for 
variables.  We found therapist caseload mix, represented by patient variables aggregated at 
the therapist level, was not associated with outcome. However, therapists' personal qualities 
may have more impact, as indicated by recent research (e.g. Green et al., 2014; Goldberg et 
al., 2016; Nissen-Lie et al., 2015; Wampold et al., 2017). 
Clinic effects 
We know of only one previous study that has estimated the size of clinic effects using 
MLM, finding a smaller but broadly comparable effect of 1.8%, in a 2-level model using a 
different outcome measure and dataset (Pybis et al., 2017). Approximately half of the 
unadjusted clinic effect was explained by patient-level severity and employment status, 
suggesting a selection effect. This has important implications for healthcare providers using 
pay for performance (a.k.a. outcomes-based) payment models. Our study found that a 
considerable additional amount of variability between clinics was explained by two clinic 
level variables. These clinic level variables were the clinic sector and the percentage of a 
clinic¶s population who were White English/European. Compared to other sectors, treatment 
in a secondary care clinic was associated with poorer outcomes. Secondary care clinics tend 
to work with patients with more complex or treatment-resistant difficulties that may not have 
been fully captured in the available variables. The second clinic level variable, the percentage 
of a clinic¶s population that were White English/European, was a more surprising finding, 
particularly as it was in addition to DQLQGLYLGXDOSDWLHQW¶V ethnic origin and explained more 
of the outcome variance.  
Ethnic origin, deprivation, and location  
The finding that larger proportions of ethnic minority patients in the clinic population 
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was associated with poorer outcomes for all patients accessing that clinic (after accounting 
for individual ethnic origin), implies that population ethnic composition reflects a distinct 
underlying factor in the population. Factors such as racism, implicit bias, and micro-
aggressions may have contributed to this effect. However, the minimal association between 
individual ethnicity and outcomes, combined with a much stronger population effect 
impacting equally on White and minority patients, arguably challenges this hypothesis. 
Further research into these factors may be beneficial to clarify any such contribution.  
Other possible explanations may be factors associated with deprivation. There is 
consistent evidence linking minority status and deprivation (Jivraj & Khan, 2013; Platt, 2007; 
United States Census Bureau, 2013), particularly in more urban areas, as in the current 
sample (Aldridge, Parekh, MacInnes, & Kenway, 2011). Analysis of 2011 UK Census data 
indicates that ethnic minorities are more likely to live in the most deprived areas. For 
example, 37% of the UK Bangladeshi population and 20% of the Caribbean population live 
in areas in the top decile of multiple deprivation, while around 7% of the White British 
population live in those areas (Jivraj & Khan, 2013). 
It might be hypothesized, therefore, that the clinic ethnic composition was a good 
proxy measure of community deprivation. This would support a recent UK study of national 
primary care data that showed locality deprivation to be associated with patient outcomes 
(Clark et al., 2018). Therefore, clinics with relatively poorer outcomes may have served 
relatively more deprived communities, and the clinic effect detected in this study may in part 
reflect a neighborhood or locality effect. An alternate, but complementary, hypothesis is that 
deprivation may be impacting on provision of care due to reduced funding and resources. 
This would be an example of the inverse care law (Hart, 1971).   
One implication of our findings is that comparisons of clinic effectiveness can only be 
fair if the characteristics of their patient populations are taken into consideration in the 
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analysis. Failure to do so may result in clinics in more deprived areas or with more difficult to 
treat patients being penalized. Further studies are required that include therapist and clinic 
variables along with socioeconomic and geographic variables to tease apart their unique 
contributions to patient outcome. These should include variables such as income per patient, 
measures of neighborhood or area-level deprivation, and the racial and ethnic characteristics 
of clinicians and clinic staff or the presence of cultural competence training.  
Caveats 
The findings above come with a number of caveats, most of which concern the data 
sample. The disadvantages (and advantages) of using routinely collected data for research 
purposes have been well documented (e.g., Barkham, Stiles, Lambert, & Mellor-Clark, 
2010). However, as it is routine data that is used administratively to monitor and compare 
clinic effectiveness, there is a strong argument for using this same data to study the variability 
in outcomes in clinics. In the current study, although the large sample allowed for multilevel 
analysis, the lack of therapist and clinic variables ± a limitation of UK service datasets 
generally ± limited our understanding of the possible reasons for the variability found.  
Despite the large sample, wide CIs in the caterpillar plots and PrIs for the clinic 
effects in particular indicate a degree of uncertainty regarding some of the findings. Future 
studies with larger clusters might produce more robust estimates for model parameters. 
The final caveats concern the generalizability of findings. They came from a 
heterogeneous sample of UK clinics and may not be generalizable to clinics in other countries 
with different configurations of provision and different clinic population characteristics. Also, 
as outcome measures came mainly from patients who completed therapy, the results may 
only be generalizable to therapy completer samples. Naturalistic data, including the present 
data are not well-suited to intention to treat analyses, DVD³ILUVW-observation-carried-IRUZDUG´
approach would have considerably reduced variability due to large numbers of patients 
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showing no apparent pre-post change (Barkham, Stiles, Connell, & Mellor-Clark, 2012). 
Large multi-clinic datasets containing sessional outcome measures are greatly needed in 
order that analyses can appropriately model non-completion.  
Conclusion  
Our primary aim was to estimate the size of therapist and clinic effects using a three- 
level model. Confirming previous findings, patient outcomes varied systematically across 
both therapists and clinics, with patient severity being the variable most strongly associated 
with outcome variability. However, the overarching implication of our findings is that the 
effectiveness of therapy is not restricted to the therapist-patient interaction, and that the 
broader sociodemographic, socioeconomic, and geographic context in which the patient lives 
and in which the therapy is provided may substantially contribute to patient outcome. 
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Table 1 
Comparisons between included and excluded patients 
Variable Included 
patients  
(n = 26888) 
Excluded 
patients  
(n = 77586) 
Included/excluded difference  Effect size 
Mean patient age (SD) 38.4 (12.9) 34.8b (13.2) t(49127.5) = -38.3* &RKHQ¶Vd = 0.28 
Female 69.3% 66.0%c Ȥ2(1, N = 103082) =  97.8* OR = 1.16 
White 90.2% 84.3%d Ȥ2(1, N = 92877) =  541.8* OR = 1.71 
Employment statusa 
Employed 
Other role 
Not employed 
 
60.4% 
25.6% 
14.0% 
 
40.1%e 
42.0%e 
17.8%e 
Ȥ2(2, N = 100084) =  3361.8*  
OR = 2.28 
OR = 0.48 
OR = 0.75 
Mean pre-therapy CORE-OM (SD) 17.8 (6.2) 18.3 (6.8)f t(56429.1) = 9.4* &RKHQ¶Vd =  0.08 
Mean post-therapy CORE-OM (SD) 8.8 (6.3) 9.8 (7.0)g t(17454.0) = 12.7* &RKHQ¶Vd =  0.15 
Mean therapy sessions (SD) 8.1 (9.0) 7.8 (13.9)h t(61566.7) = -3.1* &RKHQ¶Vd =  0.03 
Mean session attendance (SD) 90.2% (15.5) 76.3% (26.2)h t(59958.3) = -82.9* &RKHQ¶Vd = 0.65 
Planned ending 92.0%i 49.9%j Ȥ2(1, N = 63543) =  12580.6* OR = 11.55 
CORE-OM = Clinical Outcomes in Routine Evaluation ± Outcome Measure.  
aemployment status categories defined as follows: employed (part-time employment, full-time employment), not employed 
(receiving benefits, unemployed, retired), other role (part-time student, N/A, houseperson, full-time student, other), bn = 
72423, cn = 76194, dn = 65989, en = 73196, fn = 59027, gn =10479, hn =35896, in= 26780, jn = 36763. 
* p < .001. 
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Table 2 
Proportion of residual variance from an empty 3 level model explained by each additional fixed effect 
variable, in order of input to an incremental 3 level model.  
  Additional Percentage of Original Variance Explained  
Variable Level of model Overall (%) Level 3 (%) Level 2 (%) Level 1 (%) 
Patient Severity Level 1 (Patient)  17.1 29.6 12.4 16.2 
Patient Employment Level 1 (Patient)  1.1 16.4 1.9 0.8 
Sector Level 3 (Clinic) 0.5 16.1 <0.1 <0.1 
Percentage White Level 3 (Clinic) 0.4 19.6 0.4 <0.1 
Patient Ethnic Origin Level 1 (Patient)  <0.1 0.5 <0.1 0.1 
Patient Attendance Level 1 (Patient)  <0.1 <0.1 1.6 0.1 
Patient Age Level 1 (Patient) <0.1 0.2 2.0 0.2 
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Figure 1. Inclusion and exclusion of patients from the Clinical Outcomes in Routine Evaluation 
(CORE) national database. CORE-OM = CORE Outcome Measure. 
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Figure 2. Markov Chain Monte Carlo estimated caterpillar plots of clinic variability (top) and 
therapist variability (bottom) 
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Figure 3. Markov Chain Monte Carlo estimated community effect and therapist effects with 
no explanatory variables (left), and after the inclusion of all significant explanatory variables 
(right). Vertical lines indicate 95% probability intervals for each effect. 
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Figure 4. Iterative Generalised Least Squares (IGLS) estimated clinic effect and therapist effect, as 
each explanatory variable is incrementally added to the multilevel model (IGLS estimated values do 
not necessarily correspond exactly to Markov Chain Monte Carlo estimated values).  
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Figure 5. Predicted outcome scores for White and non-White patients treated at clinics with different 
percentages of White patients in their populations from 50% - 100% (Markov Chain Monte Carlo 
estimation). 
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Supplemental Material: 
The final Markov Chain Monte Carlo multilevel model specification is included below for 
those with experience of multilevel models. CORE = Clinical Outcomes in Routine 
Evaluation ± Outcome Measure score.  
 
  
